Companies: 49,246 Total Market Cap: 132591774254860.43

ChemoMetec A/S

CPH-CHEMM
Healthcare Medical Devices
Rank #7660
Market Cap 1.37 B
Volume 13,671
Price 79.87
Change (%) 1.63%
Country or region Denmark Denmark

ChemoMetec A/S's latest marketcap:

1.37 B

As of 05/20/2025, ChemoMetec A/S's market capitalization has reached $1.37 B. According to our data, ChemoMetec A/S is the 7660th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 1.37 B
Revenue (ttm) 69.13 M
Net Income (ttm) 25.43 M
Shares Out 17.40 M
EPS (ttm) 1.46
Forward PE 41.68
Ex-Dividend Date 10/11/2024
Earnings Date 05/07/2025
Market Cap Chart
Data Updated: 05/20/2025

ChemoMetec A/S's yearly market capitalization.

ChemoMetec A/S has seen its market value drop from kr10.06 B to kr9.09 B since 2020, representing a total decrease of 9.60% and an annual compound decline rate (CAGR) of 2.27%.
Date Market Cap Change (%)
05/20/2025 kr9.09 B 6.85%
12/30/2024 kr8.46 B 25.31%
12/29/2023 kr6.75 B -43.81%
12/30/2022 kr12.02 B -17.11%
12/30/2021 kr14.50 B 44.12%
12/30/2020 kr10.06 B

Company Profile

About ChemoMetec A/S

ChemoMetec A/S is a global leader in the development, production, and sale of analytical equipment for cell counting and analysis. The company serves customers in the United States, Canada, Europe, and internationally.

Key Focus Areas

  • Cell and Gene Therapy
  • Cancer and Stem Cell Research
  • Pharmaceutical Development & Manufacturing
  • Quality Control in Animal Semen, Milk, and Beer Production

Product Portfolio

  • NucleoCounter NC-3000 – Advanced image cytometer
  • NucleoCounter NC-250 – Automated cell analyzer
  • NucleoCounter NC-202 – Consistent cell counter
  • NucleoCounter NC-200 – Automated cell counter for viability determination
  • NucleoCounter SP-100 – Automated sperm cell counter for animal reproduction
  • XcytoMatic 40 – Cell density and viability analyzer

Additional Offerings

  • Consumables – Cassettes, reagents, lysis, and slides
  • Accessories – Cables, power supplies, software, and labware
  • Services – Validation plans, training, and support

The company is also developing the XcytoMatic 30 cell counter to expand its product range.

Founded: 1997 | Headquarters: Allerød, Denmark

Frequently Asked Questions

As of 05/20/2025, ChemoMetec A/S (including the parent company, if applicable) has an estimated market capitalization of $1.37 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

ChemoMetec A/S global market capitalization ranking is approximately 7660 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Denmark
Founded 1997
IPO Date n/a
Employees 174
CEO Martin Behrens
Sector Healthcare
Industry Medical Devices
Address Gydevang 43
Allerød, 3450
Denmark
Website https://chemometec.com
People Also Watch
ABT
135.55 1.63%
BSX
106.22 1.63%
Stryker
393 1.63%
Medtronic plc
86 1.63%